Authors:
Zinda, MJ
Johnson, MA
Paul, JD
Horn, C
Konicek, BW
Lu, ZH
Sandusky, G
Thomas, JE
Neubauer, BL
Lai, MT
Graff, JR
Citation: Mj. Zinda et al., AKT-1,-2, and-3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon, CLIN CANC R, 7(8), 2001, pp. 2475-2479
Authors:
Adlington, RM
Baldwin, JE
Becker, GW
Chen, BN
Cheng, LF
Cooper, SL
Hermann, RB
Howe, TJ
McCoull, W
McNulty, AM
Neubauer, BL
Pritchard, GJ
Citation: Rm. Adlington et al., Design, synthesis, and proposed active site binding analysis of monocyclic2-azetidinone inhibitors of prostate specific antigen, J MED CHEM, 44(10), 2001, pp. 1491-1508
Authors:
McNulty, AM
Audia, JE
Bemis, KG
Goode, RL
Rocco, VP
Neubauer, BL
Citation: Am. Mcnulty et al., Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5 alpha-reductase, J STEROID B, 72(1-2), 2000, pp. 13-21
Authors:
Graff, JR
Konicek, BW
McNulty, AM
Wang, ZJ
Houck, K
Allen, S
Paul, JD
Hbaiu, A
Goode, RG
Sandusky, GE
Vessella, RL
Neubauer, BL
Citation: Jr. Graff et al., Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27(Kip1) expression, J BIOL CHEM, 275(32), 2000, pp. 24500-24505